Prelabor Rupture of Membranes Clinical Trial
Official title:
To Study the Effectiveness and Safety of Oxytocin Induction in Full Term Pregnant Women With Cesarean Section of Prelabor Rupture of Membranes: a Multi-center, Prospective, Observational Study
This study is a multi-center, prospective, observational clinical trial study. 528 full-term pregnant women will be enrolled as subjects, and the ratio of eligible subjects in the two groups is 1:1. In the cesarean section group, full term pregnant women with prelabor rupture of membrane (PROM) who are willing to try the trial of labor after cesarean (TOLAC) and in accordance with the criteria according to the 2016 China vaginal birth after cesarean (VBAC) clinical management guidelines will be enrolled and recorded by our homemade registration form of TOLAC. In the non-cesarean section group, pregnant women after 37 weeks of gestation with PROM but without vaginal labor contraindications will be enrolled. Whether in the cesarean section group or non-cesarean section group, if spontaneous labor does not occur, and they all will be induced by oxytocin. After 24 hours, their final delivery mode will be recorded. In the following 42 days postpartum, their complications and the neonatal outcome will be followed up.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04558996 -
Spanish Registry of Pregnant Women With COVID-19
|
||
Recruiting |
NCT03399266 -
Balloon Induction of Labor in PROM for TOLAC
|
N/A | |
Not yet recruiting |
NCT05430711 -
Dinoprostone Induction vs. Expectant Management After PROM at Term
|
Phase 4 | |
Not yet recruiting |
NCT00294242 -
Safety Study of Membrane Sweeping in Pregnancy
|
Phase 3 | |
Completed |
NCT05215873 -
Induction of Labor in Pregnant Women With Prelabor Rupture of Membranes - Oxytocin or Misoprostol
|
Phase 4 | |
Recruiting |
NCT04143685 -
Labor Induction With Misoprostol Versus Oxytocin in Women With Premature Rupture of Membranes
|
N/A |